vimarsana.com

Page 5 - ஹடாஸா பல்கலைக்கழகம் மருத்துவமனை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Jerusalem Day violence: Hundreds of Palestinians wounded in clashes on Temple Mount

Israeli police decided to break up a contentious Jewish march in Jerusalem on Monday after rocket fire from the Gaza Strip, as tensions in the city are running high after days of violent clashes involving Israeli police, Muslim worshippers and both Jewish and Palestinian protesters. Clashes which unfolded Monday morning on the Temple Mount compound left more than 300 Palestinians wounded, according to the Palestinian Red Crescent, prompting an Israeli decision to bar Jews from entering the holy site, one of several flashpoints in the city, as Muslims mark the final days of Ramadan and Jewish Israelis celebrate Jerusalem Day. LIVE UPDATES

Startup founded by top Israeli cardiologist detects heart disease via smartphone

The HearO app has been granted breakthrough device designation by the FDA (HearO) The sound of your voice could save your life. That’s the science behind HearO, a smartphone app that can detect subtle changes in voice tone to diagnose congestive heart failure, a disease that kills millions of people every year. By the time patients suffering from congestive heart failure begin to feel symptoms and visit the doctor, it is often too late to treat them effectively. More than half die within five years of diagnosis. The app is the brainchild of Cordio Medical, an Israel startup founded by Prof. Chaim Lotan, director of the Heart Institute at Hadassah University Hospital in Jerusalem. The FDA has granted breakthrough device designation to HearO, which uses artificial intelligence and speech signal processing algorithms to detect subtle voice changes that begin at the earliest stages of congestive heart failure, before other symptoms appear.

Aiming for single-dose home-grown COVID vaccine, Israel considers redoing clinical trials

Get email notification for articles from Ido Efrati Follow May. 4, 2021 6:18 PM Israel’s Institute for Biological Research is considering restarting its ongoing clinical trial from the beginning on the COVID-19 vaccine that it is developing. The step would be taken in the hope of developing a version that is effective with a single dose, Haaretz has learned. According to sources, it became apparent from the first and second phases of the clinical trials on the two-shot Israeli BriLife vaccine that it would be possible to forgo the second shot if patients were given a higher dose in a single injection.

The master plan for building in Jerusalem? Preserve a Jewish majority

Get email notification for articles from Nir Hasson Follow Apr. 15, 2021 11:29 AM Arnon Gafni is an unknown figure in the history of Jerusalem. No street or square is named after him, not even a viaduct. But Gafni has influenced the lives of many a Jerusalemite, and not necessarily because he was the governor of the Bank of Israel in the late ‘70s. To a great extent, Gafni was responsible for laying down a principle that helped shape the capital. In 1972, as chief of the Finance Ministry’s Budgets Department, Gafni headed an interministerial committee on Jerusalem’s desired growth rate. The main issue: a “Jewish majority.”

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.